{
    "success": true,
    "data": {
        "leverage": false,
        "derivatives": false,
        "swaps": false,
        "inverse": false,
        "replication_method": "physical",
        "ucits": true,
        "type": "ETF",
        "complex_factors": [],
        "classification": "non-complex",
        "supporting_data": "The Amundi Global Bioenergy UCITS ETF EUR Acc is classified as non-complex primarily due to its UCITS status. MiFID II Article 254 and Delegated Regulation EU 2017/565 Article 57, as well as ESMA guidelines (CESR/09-295, Section 3, paragraph 69), generally presume UCITS funds to be non-complex because they operate under strict regulatory requirements. The fund employs a 'Direct Replication' method to track the Bloomberg BioEnergy Screened Index, primarily by holding the underlying securities, which is considered a transparent and straightforward approach, supporting a non-complex classification. While the fund states it 'will be able to use derivatives in order to deal with inflows and outflows and also if it allows a better exposition to an Index constituent', this use is explicitly for efficient portfolio management (EPM) and not integral to achieving its investment objective through complex structuring. The provided rules state that if derivatives are used only for EPM with minimal impact, the ETF is non-complex, and the 'derivatives' field should be false. The document does not explicitly mention the use of 'swaps' for any purpose, which would otherwise trigger a complex classification based on the specific instruction in the prompt. Securities lending is mentioned for generating additional income, which introduces counterparty risk, but this is a secondary feature and does not automatically lead to a complex classification if well-managed within UCITS rules. The underlying index, Bloomberg BioEnergy Screened Index, appears transparent, tracking companies in the bioenergy sector based on revenue and ESG standards, without indicating complex features such as roll costs, contango, or backwardation effects. The risk rating of 5/7 reflects market risk from equity investments, not structural complexity. There is no indication of significant leverage, embedded derivatives as a central feature, or 'structured UCITS' characteristics (e.g., algorithm-based payoffs) that would override the non-complex presumption for UCITS."
    }
}